talactoferrin alfa has been researched along with Carcinoma, Renal Cell in 2 studies
talactoferrin alfa: recombinant human lactoferrin, an oral drug for treatment of refractory solid tumors; in Phase I trial 5/2006
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-six patients with metastatic cancer who had progressed on, or were ineligible for, standard chemotherapy received single-agent oral talactoferrin." | 2.75 | Phase IB trial of oral talactoferrin in the treatment of patients with metastatic solid tumors. ( Falchook, GS; Hayes, TG; Varadhachary, A, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayes, TG | 2 |
| Falchook, GS | 1 |
| Varadhachary, A | 2 |
| Jonasch, E | 1 |
| Stadler, WM | 1 |
| Bukowski, RM | 1 |
| Malik, R | 1 |
| Figlin, RA | 1 |
| Srinivas, S | 1 |
2 trials available for talactoferrin alfa and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Phase IB trial of oral talactoferrin in the treatment of patients with metastatic solid tumors.
Topics: Administration, Oral; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal | 2010 |
Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Disease-Free Survival; Drug Administration Schedule; F | 2008 |